NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
about
Notch Signaling in Neuroendocrine TumorsCellular and molecular biology of small cell lung cancer: an overviewNrf2 and Notch Signaling in Lung Cancer: Near the CrossroadHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsSelective gene expression analysis of the neuroepithelial body microenvironment in postnatal lungs with special interest for potential stem cell characteristics.Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.The Emerging Role of Cdk5 in CancerMolecular mechanisms of therapy resistance in solid tumors: chasing "moving" targets.In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer.Classification of pulmonary neuroendocrine tumors: new insights.Update on large cell neuroendocrine carcinoma.Small-cell lung cancer: what we know, what we need to know and the path forward.Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse.Notch signaling triggers the tumor heterogeneity of small cell lung cancer.Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center.[Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors].Inhibition of Cdk5 induces cell death of tumor-initiating cells.Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression.Transformation to small cell lung cancer after first-line afatinib treatment.Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.Combined small-cell lung carcinoma.
P2860
Q26752380-48963198-D82F-4889-A82A-CB68C65315C4Q26767029-7540784D-51E2-4705-A7DE-719D613CE8EFQ28066915-11ECFFB0-9A83-44B3-B84E-63D152FDD30AQ28077504-1DB247B9-3BF4-48E8-8BEF-56349D548E21Q33651475-382F2912-0C33-45B8-A4FB-D568EF62E0F1Q36035933-8BD9BCEA-F6E7-4125-9A25-BEAA9F5430D8Q37544346-712CC8AE-E365-4B79-B0D9-18A04ADE15C9Q38707443-6ED241F3-72D6-415D-A1B9-22DA685FA49FQ38754603-90930813-6D8B-427E-B3CE-79F7E515F424Q38992148-88161D13-B4E4-42DA-99EB-EBCD9CA59AD9Q39029140-FB9318E8-9313-4411-89F3-F095E6A6BE4AQ39172297-6410AB4E-5FE0-4A0D-8292-35934367C1B5Q39430735-32A5AC02-5F01-4BAF-9953-C5104E7090DCQ39934413-98332F5B-490C-408E-A523-592347CB8C5FQ41683785-3C36D09D-C873-4AB8-938A-DC9D1B44A97DQ45140096-ED18BDF4-E16D-4B70-BA53-E2110C150830Q46316777-05E8A211-A62A-4BBD-9D7B-454BA91684C9Q47595394-FCEF7FD4-FB0A-47A0-BEFF-A1122A68BBCCQ47630582-92F4FE01-7F57-40FB-8059-4CD8CAD3CC03Q49393089-286E8E6F-1C57-4182-B9DF-E802BCB7DB30Q49913498-819B1834-1997-462F-A58B-FE40F82B9D5BQ50072136-13CC1C86-CCF8-4F05-B3E8-88EDC10DAB08Q50880834-43D051AB-08D3-4E6A-BA65-72E2021EAEDFQ54118413-645F9410-06BD-4F96-8C98-EE6ABD034B73Q54979885-B8D56742-70F1-4B3C-AEBE-0AC29C22AA94Q55141745-60B0854E-46C8-4ECF-BE62-00BBF294CCF4Q55332272-0DBF5270-E391-4487-8CE2-D9557AD81F86
P2860
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NOTCH, ASCL1, p53 and RB alter ...... nd small cell lung carcinomas.
@en
type
label
NOTCH, ASCL1, p53 and RB alter ...... nd small cell lung carcinomas.
@en
prefLabel
NOTCH, ASCL1, p53 and RB alter ...... nd small cell lung carcinomas.
@en
P2093
P2860
P356
P1476
NOTCH, ASCL1, p53 and RB alter ...... nd small cell lung carcinomas.
@en
P2093
Alexandra Florin
Anne M Schultheis
Carsten P Ade
Diana Boehm
Frank Ueckeroth
Jürgen Wolf
Katharina König
Kerstin Albus
Luka Ozretić
Lukas C Heukamp
P2860
P304
P356
10.1002/IJC.29835
P577
2015-09-04T00:00:00Z